This molecular interaction highlights a potential mechanism by which SARS-CoV-2 may directly impact the intricate balance of hemostasis, providing valuable insights for understanding the pathophysiology of COVID-19-associated coagulopathies and suggesting new avenues for targeted therapeutic interventions aimed at restoring or mitigating PROS1 functionality. Here, PROS1 is linked to COVID-19.